Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
52004 | Belnacasan | 273404-37-8 | 98% | |
Belnacasan is a prodrug ofVRT-043198, a caspase-1 inhibitor that was developed by Ver | ||||
2071401 | Pimodivir ( VX-787 ) | 1629869-44-8 | 98% Min. | |
Pimodivir, also known as VX-787, JNJ-872, is a novel inhibitor of influenza virus rep | ||||
2073107 | Trilaciclib hydrochloride (G1T28 hydrochloride) | 1977495-97-8 | 98% Min. | |
TRILACICLIB (G1T28), A HIGHLY POTENT, TRANSIENT CDK 4/6 INHIBITOR WITHIC50s OF 1 nM A | ||||
2073108 | PF-06802861 ( ARRY 371797 ; ARRY-797 ) | 1034189-82-6 | ≧98.0% | |
ARRY 797 (also known as ARRY 371797 or PF 06802861) is an orally active, selective p3 | ||||
208191 | OATD-01 (GLPG-4716) | 2088453-21-6 | ≧98.0% | |
OATD-01 (GLPG-4716), a dual inhibitor of acidic mammalian chitinase (AMCase) and chit | ||||
2091501 | AB-680 | 2105904-82-1 | 98% Min. | |
AB-680 is highly potent, reversible and selective CD73 inhibitor. AB680 to be a rever | ||||
2091502 | 5-(chloromethyl)-1-propyl-1H-imidazole hydrochloride | 497223-15-1 | ≧95.0% | |
5-(chloromethyl)-1-propyl-1H-imidazole hydrochloride is an important intermediate of | ||||
2091906 | BAY-2416964 | 2242464-44-2 | 98% Min. | |
BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist | ||||
20103001 | ASN007 | 2055597-12-9 | ≧98.0% | |
ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tum | ||||
20103002 | Senaparib | 1401682-78-7 | ≧98.0% | |
Senaparib (IMP4297) is a novel agent targeting PARP (poly-ADP ribose polymerase) with | ||||
20103004 | 2,6-difluoro-3,5-dimethoxybenzeneamine | 651734-54-2 | ≧98.0% | |
2,6-difluoro-3,5-dimethoxybenzeneamine is a key intermeidate ofPemigatinib.1Kg~10Kg s | ||||
201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% | |
Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1